How A.I. Is Revolutionizing Drug Developmentnews2024-06-17T09:03:08+00:00June 17th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
A Fraught New Frontier in Telehealth: Ketaminenews2023-02-20T08:00:06+00:00February 20th, 2023|The New York Times|
Start-Up Paradigm Raises $200 Million to Speed Up Drug Trialsnews2023-01-27T10:00:17+00:00January 27th, 2023|The New York Times|
Startups Prescribing A.D.H.D Drugs on TikTok Raise Diagnosis Concernsnews2022-05-13T21:12:48+00:00May 13th, 2022|The New York Times|
Elizabeth Holmes Trial: Closing Arguments Are Set to Beginnews2021-12-17T00:07:25+00:00December 17th, 2021|The New York Times|
Elizabeth Holmes Points Fingers at Others and Says She Was a Believernews2021-11-24T00:33:27+00:00November 24th, 2021|The New York Times|
Elizabeth Holmes Trial Exposes Investors’ Lack of Due Diligencenews2021-11-04T20:14:14+00:00November 4th, 2021|The New York Times|
Elizabeth Holmes Trial: Key Moments From Week 6news2021-10-15T21:11:37+00:00October 15th, 2021|The New York Times|
‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranosnews2021-08-27T16:08:36+00:00August 27th, 2021|The New York Times|
